Is Ozempic (Semaglutide) Right For Me? - podcast episode cover

Is Ozempic (Semaglutide) Right For Me?

Apr 25, 202240 minSeason 1Ep. 115
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Health Canada recently approved a new weight loss drug, semaglutide, also known as “Ozempic” or “Wegovy.” Experts refer to it as a “game changer” for its ability to curtail appetite and spur weight loss. In this episode, Medcan’s director of weight management, Dr. David Macklin, a co-author of Canada’s national guidelines for obesity treatment, provides host Shaun Francis with a semaglutide explainer. “We’re in a super exciting stage in my field of medicine,” Dr. Macklin says.

Check out episode highlights and links on our webpage.

For the best experience, listen in Metacast app for iOS or Android